menu search

Bristol myers squibb revenue falls on generic competition for key drug

Shares of Bristol Myers Squibb (BMY) fell Thursday after the company reported that sales of the drug maker's popular Revlimid blood cancer treatment p...

October 26, 2023, 4:55 pm

Novartis raises outlook after sandoz generics spinoff

Novartis CEO Vas Narasimhan discusses third-quarter results with the company lifting its profit forecast for a third time as he calls the drugmaker a ...

October 24, 2023, 6:24 am

Mirati stock falls as bristol myers to buy oncology developer for up to $5.8 billion

The acquisition will help boost revenue by offsetting upcoming competition from generics for Bristol My...

October 9, 2023, 5:27 am

Novartis spin-off completed as sandoz makes subdued start on swiss bourse

Swiss drugs giant Novartis AG has completed the spin-off of its generics business Sandoz, which made an...

October 4, 2023, 7:13 am

Novartis unit sandoz set to start trading after completing spinoff

Novartis has completed the planned spin-off of its generics and biosimilars business, Sandoz, which wil...

October 4, 2023, 1:51 am

Novartis completes sandoz spinoff

Novartis has completed the planned spin-off of its generics and biosimilars business Sandoz , the Swiss...

October 4, 2023, 1:20 am

Swiss government generics push could cut 250 million from health bill

Many drugs come in two forms: expensive branded drugs and cheaper generic copies. Switzerland’s Federal Council hopes a shift to cheaper generic and...

September 22, 2023, 4:14 pm

Tablet coatings market size to exceed usd 824 million by 2031, demonstrating a notable cagr of 5.3%: tmr report

Increase in emphasis on superior pharmaceutical products, generics, and biosimilars has led to a rise i...

August 23, 2023, 11:46 am

Here's why you should add dr. reddy's (rdy) to your portfolio

Dr. Reddy's (RDY) continues to enjoy a strong foothold in the global generics market due to its deep ge...

August 18, 2023, 2:05 pm

Viatris (vtrs) q2 earnings beat, generics business grows

Viatris (VTRS) second-quarter earnings and sales beat estimates. The company reiterates its annual guidance....

August 7, 2023, 1:38 pm

Assertio holdings: promising small cap with strong financials and strategic plans

Assertio Holdings, a pharmaceutical company, has demonstrated solid financials and growth potential, with a focus on reducing debt levels and increasi...

June 15, 2023, 8:05 am

Novartis' sandoz to generate additional $3 bln in net sales over next five years

Novartis' soon to be spun off generics division Sandoz is expected to expand its pipeline and generate ...

June 8, 2023, 1:38 am

Dr. reddy's laboratories: unpacking the critical factors, reiterate buy

Dr. Reddy's Laboratories Ltd. (RDY) remains an attractive investment due to its strong Q4 and FY'23 numbers, exposure to the Indian ...

June 7, 2023, 7:34 am

Looking for passive income at a decent price? buy these 2 stocks

High-quality dividend stocks typically aren't cheap. Viatris has a great roster of medicines on the market, with more ...

June 5, 2023, 5:05 am

Teva pharmaceutical announces new growth strategy built on biosimilars, innovation

Teva Pharmaceutical Industries on Thursday launched a new “pivot to growth” strategy, based on existing growth drivers like Austedo and Ajovy as w...

May 18, 2023, 9:05 am

Amneal pharmaceuticals' stock soars 14% premarket after company offers upbeat q1 guidance

Amneal Pharmaceuticals Inc.'s stock AMRX, -2.16% soared 14% in premarket trade Monday, after the generics...

April 17, 2023, 6:53 am

3 healthcare spinoffs worth a look, but 1 has the best long-term potential

Embecta should benefit from the greater need for diabetic services. Viatris is focusing on finding new generic...

March 26, 2023, 8:45 am

Better generics pharmaceutical stock: teva or viatris?

Teva is the world's largest maker of generic drugs. Viatris offers an above-average dividend yield....

March 5, 2023, 11:28 am

Hikma pharmaceuticals plc (hkmpf) q4 2022 earnings call transcript

Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q4 2022 Earnings Conference Call February 23, 2023 6:00 AM ET Company Participants Susan Ringdal - EVP, Strate...

February 26, 2023, 1:13 pm

Taro pharmaceutical: stagnating growth at 1.6% trailing earnings yield, rate hold

Taro Pharmaceutical's quarterly numbers came in with very thin growth at the operating and bottom-lines given the impact from settlement charges. Pric...

February 24, 2023, 12:18 am


Search within

Pages Search Results: